Objective: To systematically review the literature for studies reporting on
recurrence rates of basal cell carcinomas (BCCs) after different therapies
.
Design: We reviewed all studies published in English, French, German, Dutch
, Spanish, or Italian between 1970 and 1997 that prospectively examined rec
urrence rates for at least 50 patients with primary BCCs observed for at le
ast 5 years after treatment with Mohs micrographic surgery, surgical excisi
on, curettage and electrodesiccation, cryosurgery, radiotherapy, immunother
apy with interferon or fluorouracil, or photodynamic therapy.
Setting: Department of Dermatology, University Hospital Maastricht, Maastri
cht, the reference center for dermatologic oncology and Mohs micrographic s
urgery in the Netherlands.
Main Outcome Measures: The recurrence rates after different therapies for B
CCs, resulting in the development of guidelines for the treatment of these
disorders.
Results: Of 298 studies found in several electronic databases, only 18 met
the requirements and could be used for analysis. Tumors treated with Mohs m
icrographic surgery show the lowest recurrence rates after 5 years, followe
d in order by those treated with surgical excision, cryosurgery, and curett
age and electrodesiccation,
Conclusions: Recurrence rates for different therapies could not be compared
because of a lack of uniformity in the method of reporting, so evidence-ba
sed guidelines could not be developed. We surmise that Mohs micrographic su
rgery should be used mainly for larger, morphea-type BCCs located in danger
tones. For smaller BCCs of the nodular and superficial types, surgical exc
ision remains the first treatment of choice. Other treatment modalities can
be used in patients in whom surgery is contraindicated. Immunotherapy and
photodynamic therapy are still investigative.